EV/EBITDA
19.78
-0.22-1.10%
Fri, 21 Feb 2025 21:20:00 GMT
Summary
- As of February 22, 2025, LGND EV/EBITDA is 19.78, with a fall of -0.22 (-1.10%) during the most recent trading day.
- Over the past year, LGND EV/EBITDA has increased by +6.86 (+53.10%).
- LGND EV/EBITDA is now -97.67% below its all-time high of 850.30.
Performance
LGND EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
LGND EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.1% | -1.1% | -1.1% |
| 1 m1 month | +2.3% | +2.3% | +2.3% |
| 3 m3 months | +3.7% | +3.6% | +3.5% |
| 6 m6 months | +62.1% | +13.5% | +11.9% |
| ytdytd | +13.2% | +13.1% | +12.8% |
| 1 y1 year | +53.1% | +72.2% | +61.9% |
| 5 y5 years | +672.7% | -0.8% | +19.8% |
LGND EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.5% | 18.11 | +9.2% | |
| 3 m | 3-month | 20.59 | -3.9% | 16.31 | +21.3% |
| 6 m | 6-month | 20.59 | -3.9% | 11.01 | +79.7% |
| 1 y | 1-year | 20.59 | -3.9% | 7.62 | +159.6% |
| 3 y | 3-year | 22.52 | -12.2% | 5.53 | +257.7% |
| 5 y | 5-year | 850.30 | -97.7% | 1.85 | +969.2% |
| alltime | all time | 850.30 | -97.7% | -8867 | +100.2% |
Ligand Pharmaceuticals Incorporated EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 19.78(+13.2%) |
| 2024 | 17.48(+41.1%) |
| 2023 | 12.39(+15.5%) |
| 2022 | 10.73(-47.1%) |
| 2021 | 20.28(-42.8%) |
| 2020 | 35.43(+1232.0%) |
| 2019 | 2.66(-81.1%) |
| 2018 | 14.06(-61.9%) |
| 2017 | 36.93(-48.9%) |
| 2016 | 72.25(-4.6%) |
| 2015 | 75.70(+64.2%) |
| 2014 | 46.10(-20.0%) |
| 2013 | 57.61(-50.3%) |
| 2012 | 115.99(+38.9%) |
| 2011 | 83.49(-742.2%) |
| Date | Value |
|---|---|
| 2010 | -13.00(-69.3%) |
| 2009 | -42.29(+1319.1%) |
| 2008 | -2.98(-60.5%) |
| 2007 | -7.54(-52.1%) |
| 2006 | -15.73(-45.8%) |
| 2005 | -29.03(-99.7%) |
| 2004 | -8867.49(>+9900.0%) |
| 2003 | -19.91(+40.3%) |
| 2002 | -14.19(-80.4%) |
| 2001 | -72.27(+173.5%) |
| 2000 | -26.42(+68.8%) |
| 1999 | -15.65(+72.2%) |
| 1998 | -9.09(-61.0%) |
| 1997 | -23.33(+9.4%) |
| 1996 | -21.33(+2.3%) |
| 1995 | -20.85 |
FAQ
- What is Ligand Pharmaceuticals Incorporated EV/EBITDA?
- What is the all time high EV/EBITDA for Ligand Pharmaceuticals Incorporated?
- What is LGND EV/EBITDA year-to-date change?
- What is Ligand Pharmaceuticals Incorporated EV/EBITDA year-on-year change?
What is Ligand Pharmaceuticals Incorporated EV/EBITDA?
The current EV/EBITDA of LGND is 19.78
What is the all time high EV/EBITDA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high EV/EBITDA is 850.30
What is LGND EV/EBITDA year-to-date change?
Ligand Pharmaceuticals Incorporated EV/EBITDA has changed by +2.30 (+13.16%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated EV/EBITDA year-on-year change?
Over the past year, LGND EV/EBITDA has changed by +6.86 (+53.10%)